• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States

tetano

Editor, Senior Moderator
Cell Rep


. 2020 Oct 20;108352.
doi: 10.1016/j.celrep.2020.108352. Online ahead of print.
High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States


Ryan P McNamara[SUP] 1 [/SUP], Carolina Caro-Vegas[SUP] 1 [/SUP], Justin T Landis[SUP] 1 [/SUP], Razia Moorad[SUP] 1 [/SUP], Linda J Pluta[SUP] 1 [/SUP], Anthony B Eason[SUP] 1 [/SUP], Cecilia Thompson[SUP] 2 [/SUP], Aubrey Bailey[SUP] 3 [/SUP], Femi Cleola S Villamor[SUP] 1 [/SUP], Philip T Lange[SUP] 1 [/SUP], Jason P Wong[SUP] 1 [/SUP], Tischan Seltzer[SUP] 1 [/SUP], Jedediah Seltzer[SUP] 1 [/SUP], Yijun Zhou[SUP] 1 [/SUP], Wolfgang Vahrson[SUP] 4 [/SUP], Angelica Juarez[SUP] 1 [/SUP], James O Meyo[SUP] 5 [/SUP], Tiphaine Calabre[SUP] 6 [/SUP], Grant Broussard[SUP] 5 [/SUP], Ricardo Rivera-Soto[SUP] 5 [/SUP], Danielle L Chappell[SUP] 7 [/SUP], Ralph S Baric[SUP] 8 [/SUP], Blossom Damania[SUP] 1 [/SUP], Melissa B Miller[SUP] 9 [/SUP], Dirk P Dittmer[SUP] 10 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is constantly evolving. Prior studies focused on high-case-density locations, such as the northern and western metropolitan areas of the United States. This study demonstrates continued SARS-CoV-2 evolution in a suburban southern region of the United States by high-density amplicon sequencing of symptomatic cases. 57% of strains carry the spike D614G variant, which is associated with higher genome copy numbers, and its prevalence expands with time. Four strains carry a deletion in a predicted stem loop of the 3' UTR. The data are consistent with community spread within local populations and the larger continental United States. The data instill confidence in current testing sensitivity and validate "testing by sequencing" as an option to uncover cases, particularly nonstandard coronavirus disease 2019 (COVID-19) clinical presentations. This study contributes to the understanding of COVID-19 through an extensive set of genomes from a non-urban setting and informs vaccine design by defining D614G as a dominant and emergent SARS-CoV-2 isolate in the United States.

Keywords: COVID-19; SARS-CoV-2; coronavirus; mutational landscape; next-generation sequencing; single-nucleotide variations; testing by sequencing.
 
Back
Top Bottom